Voisard Asset Management Group, Inc. Editas Medicine, Inc. Transaction History
Voisard Asset Management Group, Inc.
- $240 Billion
- Q3 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 100 shares of EDIT stock, worth $328. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$328
Previous $467,000
26.98%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EDIT
# of Institutions
242Shares Held
58.9MCall Options Held
494KPut Options Held
417K-
Vanguard Group Inc Valley Forge, PA8.03MShares$26.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.78MShares$25.5 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$19.7 Million0.92% of portfolio
-
State Street Corp Boston, MA4.59MShares$15.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.46MShares$8.07 Million0.01% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $225M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...